Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Business corporate rebranding

Splash Beverage Group Rebrands as Endovia Health Sciences

Analysis based on 11 articles · First reported Aug 12, 2026 · Last updated Aug 21, 2026

Sentiment
30
Attention
2
Articles
11
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The rebranding and strategic pivot to cannabinoid health sciences may attract investor interest and potentially boost the company's valuation as it aligns with a high-growth sector. However, the success depends on regulatory approvals and commercial execution, which carry inherent risks that could impact the stock's performance.

Pharmaceuticals Cannabis Beverages

Splash Beverage Group, Inc., a company listed on the NYSE American under the ticker SBEV, announced its transformation into Usana Health Sciences, Inc., effective August 24, 2026, with a new ticker symbol EDVA. The rebranding reflects the company's strategic shift from its legacy beverage operations to a diversified cannabinoid-based health sciences platform. The new corporate identity focuses on three complementary areas: commercial pharmaceutical assets, FDA-regulated human and veterinary therapeutics, and cannabinoid-based consumer wellness and beverage products. The company has been repositioning over the past year, acquiring pharmaceutical rights, expanding international commercialization opportunities, and advancing its CannEpil product through regulated development pathways. Recently, it opened an Investigational New Animal Drug (INAD) file with the United States — Food and Drug Administration's Center for Veterinary Medicine for CannEpil, establishing a regulatory framework for its veterinary development in the United States. The name and ticker change will not affect shareholder rights, and existing stock certificates remain valid. The company aims to build a science-driven platform with differentiated intellectual property and multiple pathways to sustainable growth.

stock
The company is undergoing a strategic transformation, rebranding to Usana Health Sciences and shifting focus to cannabinoid-based health sciences, which could enhance its growth prospects and market positioning.
Importance 100.0 Sentiment 40.0
stock
As the new corporate identity, Usana Health Sciences represents the company's future direction, focusing on pharmaceutical, veterinary, and consumer wellness markets, and is central to the rebranding event.
Importance 100.0 Sentiment 40.0
per
As Interim CEO, Brady Cobb is leading the strategic transformation and communicating the company's vision, playing a key role in the rebranding and future execution.
Importance 60.0 Sentiment 30.0
govactor
The FDA's regulatory pathways are central to the company's strategy for human and veterinary therapeutics; the opening of an INAD file for CannEpil is a step toward regulatory approval, but the FDA's role is neutral.
Importance 50.0 Sentiment 0.0
exch
The exchange will list the company under the new ticker EDVA, reflecting the corporate name change, but this is a routine administrative action with no direct impact on the exchange.
Importance 30.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.